BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15308639)

  • 1. CP-31398 restores DNA-binding activity to mutant p53 in vitro but does not affect p53 homologs p63 and p73.
    Demma MJ; Wong S; Maxwell E; Dasmahapatra B
    J Biol Chem; 2004 Oct; 279(44):45887-96. PubMed ID: 15308639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
    Mondal N; Parvin JD
    Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interplay between MDM2, p63/p73 and mutant p53.
    Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
    Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.
    Strano S; Fontemaggi G; Costanzo A; Rizzo MG; Monti O; Baccarini A; Del Sal G; Levrero M; Sacchi A; Oren M; Blandino G
    J Biol Chem; 2002 May; 277(21):18817-26. PubMed ID: 11893750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53 family: same response, different signals?
    Chen X
    Mol Med Today; 1999 Sep; 5(9):387-92. PubMed ID: 10462750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53.
    Klein C; Georges G; Künkele KP; Huber R; Engh RA; Hansen S
    J Biol Chem; 2001 Oct; 276(40):37390-401. PubMed ID: 11477076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.
    Boominathan L
    PLoS One; 2010 May; 5(5):e10615. PubMed ID: 20485546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 family members: similar biochemistry, different biology.
    Barbieri CE; Pietenpol JA
    Cancer Biol Ther; 2005 Apr; 4(4):419-20. PubMed ID: 15908776
    [No Abstract]   [Full Text] [Related]  

  • 15. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a distinct inhibitory factor in the regulation of p53 functional activity.
    Wiederschain D; Gu J; Yuan ZM
    J Biol Chem; 2001 Jul; 276(30):27999-8005. PubMed ID: 11382762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 family in scars.
    Tanaka A; Hatoko M; Tada H; Iioka H; Niitsuma K; Miyagawa S
    J Dermatol Sci; 2004 Feb; 34(1):17-24. PubMed ID: 14757278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASPP1 and ASPP2: common activators of p53 family members.
    Bergamaschi D; Samuels Y; Jin B; Duraisingham S; Crook T; Lu X
    Mol Cell Biol; 2004 Feb; 24(3):1341-50. PubMed ID: 14729977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.